StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) shareholders

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Ownership

Who owns Emmaus Life Sciences's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
4 buys · 0 sales
Net bought $15.03K

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Seah H. Lim, M.D., Ph.D.4,147,4266.50%13G (passive) amendmentDec 31, 2024

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Willis C. LeeCEO, Director1,326,4851.89%Sep 2, 2026
Henry Huy DuDirector––Apr 21, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Willis C. Lee
CEO, Director
Aug 31, 2026Buy+100,000$0.05$5.00K690,167
Willis C. Lee
CEO, Director
Aug 28, 2026Buy+94,767$0.06$5.69K590,167
Willis C. Lee
CEO, Director
Aug 27, 2026Buy+50,000$0.05$2.50K495,400
Willis C. Lee
CEO, Director
Aug 25, 2026Buy+46,000$0.04$1.84K445,400
Willis C. Lee
CEO, Director
Aug 29, 2025Buy+170,000$0.01$1.70K275,400
Willis C. Lee
CEO, Director
May 30, 2025Buy+70,000$0.02$1.40K229,400
Seah H. Lim
Director
Sep 16, 2024Buy+20,000$0.04$8004,606,626
Willis C. Lee
Co-President & COO, Director
Feb 29, 2024Buy+77,000$0.13$10.01K159,400
Willis C. Lee
Co-President & COO, Director
Feb 28, 2024Buy+15,000$0.12$1.80K82,400
Willis C. Lee
Co-President & COO, Director
Feb 27, 2024Buy+10,000$0.13$1.30K67,400
Willis C. Lee
Co-President & COO, Director
Feb 26, 2024Buy+13,200$0.12$1.58K57,400
Seah H. Lim
Director
Dec 20, 2023Sale−32,500$0.05$1.63K4,586,626
Seah H. Lim
Director
Dec 15, 2023Sale−6,000$0.11$660171,700
Seah H. Lim
Director
Dec 15, 2023Other+4,447,426$0.29$1.29M4,619,126
Wei Peu ZEN
Director
Dec 15, 2023Other+3,760,983$0.29$1.09M4,768,817
Willis C. Lee
COO, Director
Nov 30, 2023Buy+59,400$0.12$7.13K395,124
Willis C. Lee
COO, Director
Nov 30, 2023Buy+7,417$0.12$890395,124
Willis C. Lee
COO, Director
Nov 29, 2023Buy+36,000$0.12$4.32K335,724
Willis C. Lee
COO, Director
Nov 29, 2023Buy+4,325$0.12$519335,724
Willis C. Lee
COO, Director
Nov 28, 2023Buy+12,000$0.12$1.44K299,724
Willis C. Lee
COO, Director
Nov 28, 2023Buy+1,470$0.12$176299,724
Willis C. Lee
COO, Director
Nov 14, 2023Buy+1,100$0.12$13244,200
Willis C. Lee
COO, Director
Nov 14, 2023Buy+132$0.12$1644,200
Seah H. Lim
Director
Sep 5, 2023Buy+1,700$0.15$255177,700
Willis C. Lee
COO, Director
Aug 31, 2023Buy+6,000$0.15$90043,100
Willis C. Lee
COO, Director
Aug 31, 2023Buy+900$0.15$13543,100
Seah H. Lim
Director
Aug 30, 2023Buy+20,000$0.15$3.00K176,000
Willis C. Lee
COO, Director
Aug 25, 2023Buy+6,500$0.21$1.37K37,100
Seah H. Lim
Director
Aug 25, 2023Buy+92,100$0.27$24.87K156,000
Willis C. Lee
COO, Director
Aug 25, 2023Buy+1,365$0.21$28737,100
Willis C. Lee
COO, Director
May 31, 2023Buy+28,700$0.29$8.32K30,600
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Nov 30, 2022Buy+22,900$0.41$9.39K12,040,857
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Nov 29, 2022Buy+14,700$0.38$5.59K12,017,957
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Nov 28, 2022Buy+5,000$0.35$1.75K12,003,257
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Nov 4, 2022Buy+7,500$0.45$3.38K11,998,257
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Nov 3, 2022Buy+2,500$0.45$1.13K11,990,757
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Nov 2, 2022Buy+15,000$0.43$6.45K11,988,257
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Nov 1, 2022Buy+5,000$0.43$2.15K11,973,257
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 31, 2022Buy+7,500$0.45$3.38K11,968,257
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 28, 2022Buy+7,500$0.42$3.15K11,960,757
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 27, 2022Buy+22,500$0.27$6.08K11,953,257
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 26, 2022Buy+11,900$0.27$3.21K11,930,757
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 25, 2022Buy+20,000$0.26$5.20K11,918,857
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 24, 2022Buy+7,500$0.22$1.65K11,898,857
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 21, 2022Buy+10,000$0.19$1.90K11,891,357
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 20, 2022Buy+30,000$0.18$5.40K11,881,357
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 19, 2022Buy+25,000$0.16$4.00K11,851,357
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 18, 2022Buy+30,000$0.19$5.70K11,826,357
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 17, 2022Buy+15,000$0.20$3.00K11,796,357
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 14, 2022Buy+35,000$0.17$5.95K11,781,357
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 13, 2022Buy+62,500$0.18$11.25K11,746,357
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 12, 2022Buy+160,000$0.08$12.80K11,683,857
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 11, 2022Buy+5,000$0.09$45011,523,857
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 11, 2022Buy+130,000$0.09$11.70K11,518,857
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 10, 2022Buy+10,000$0.09$90011,388,857
Seah H. Lim
Director
Oct 9, 2022Buy+25,400$0.11$2.79K63,900
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 7, 2022Buy+4,000$0.13$52011,378,857
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 6, 2022Buy+5,000$0.15$75011,374,857
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 5, 2022Buy+10,000$0.15$1.50K11,369,857
Yutaka Niihara
Chairman and CEO, Director, 10% owner
Oct 4, 2022Buy+5,000$0.16$80011,359,857

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+229.2%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Emmaus Life Sciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 40,000 shares on Aug 24, 2026 over the last 90 days.

See a number that looks wrong?